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Snmuarv The association between the levels of various fatty acids in adipose breast tissue and the emergence
of visceral metastases was prospectively studied in a cohort of 121 patients with an initia!ly localised breast
cancer. Adipose breast tissue was obtained at the time of initial surgery, and its fatty acid content analysed by
capillary gas chromatography. A low level of a-linolenic acid (18:3f,3) in adipose breast tissue was associated
with positive axillary lymph node status and with the presence of vascular invasion, but not with tumour size
or mitotic index. After an average 31 months of follow-up, 21 patients developed metastases. Large tumour
size, high mitotic index, presence of vascular invasion and low level of 18:3,, were single factors significantly
associated with an increased risk of metastasis. A Cox proportional hazard regression model was used to
identify prognostic factors. Low 18:3,3 level and large tumour size were the two factors predictive of
metastases. These results suggest that host cm-linolenic acid has a specific role in the metastatic process in vivo.
Further understanding of the biology of this essential fatty acid of the n-3 series is needed in breast carcinoma.
Several epidemiological studies have shown an association
between fatty acid intake and risk of breast cancer. Plausible
mechanisms involve metabolic or structural effects of fatty
acids (Schatzkin et al., 1989). The fact that, after dietary
supplementation, several fatty acids are incorporated into
membrane phospholipids of tumour cells (Burns & Spector,
1990) suggests that these fatty acids might influence tumour
growth through an effect on membrane functions, such as
mitogenic signal transduction, as has been shown in vitro
(Speizer et al., 1991) and in vivo (Donnelly et al.. 1987;
Belury et al., 1991). We have reported that the membrane
fatty acid composition of cells from breast carcinoma can
predict the subsequent occurrence of distant metastasis:
clinically aggressive tumours have a lower polyunsaturated
fatty acid content in phosphatidylethanolamine (Lanson et
al., 1990) and a lower stearic acid content in phosphatidyl-
choline (Bougnoux et al.. 1991) compared with other
tumours with non-metastatic evolution. We have also
observed that the membrane fatty acid composition of nor-
mal breast tissue is very similar to that of carcinoma, sug-
gesting that host-dependent factors, either factors unique to
the individual or environmental factors, are important in
determining the composition of both tissues (V. Chajes et al.,
submitted).
Although the fatty acid composition of membranes has
been studied extensively, the fatty acid composition of
adipose tissue, a biological marker of past fatty acid intake
(London et al., 1991). has been the subject of few reports in
breast cancer. We report here the relationship between the
fatty acid composition of adipose breast tissue prospectively
collected from a cohort of 121 breast cancer patients and the
subsequent development of visceral metastases.
Subjects and methods
Characteristics ofpatients and disease
One hundred and twenty-one patients with non-metastatic
invasive breast carcinoma were entered into the study when
the following criteria were met: a specimen of adipose tissue
had been obtained during surgery; pathology, staging (TNM)
and treatment had been performed at the University Hospital
of Tours; and follow-up was expected to be possible (Boug-
noux et al., 1991). The mean age of patients was 56 (range
25-85). The pathological characteristics of the tumours were
reviewed by a single pathologist. Ninety-seven tumours were
of the ductal type, ten were lobular and 14 tumours were of
other types or were undetermined. Histoprognostic grading
(Bloom & Richardson, 1957) was possible in 119 patients,
and eight patients were grade I, 72 grade II and 39 grade III.
Vascular invasion was defined by the presence of tumour
cells within the lumina of blood or lymph vessels. Oestrogen
and progesterone receptors were measured in tumour cytosol
with an immunoenzyme assay (Abbott, USA). No patients
were lost to follow-up.
Treatment
Treatment procedures were based on clinical presentation
and on the value of prognostic indicators. Patients with a
disease localised to the breast had initial surgery when the
size of the tumour allowed a conservative treatment with a
good cosmetic result. Surgery consisted of a lumpectomy and
an axillary lymph node dissection. Lumpectomy was replaced
by mastectomy when several tumour foci were found, or
when the size of the breast did not permit a satisfactory
lumpectomy. Locoregional treatment included post-operative
radiation therapy, using modalities reported elsewhere (Calais
et al., 1993). Adjuvant chemotherapy was given to premeno-
pausal patients with involved axillary lymph nodes or with
other poor prognostic indicators, such as histoprognostic
grade III or vascular invasion in the tumour tissue. Post-
menopausal patients with hormone receptor levels under
10 fmol mg-' protein were given chemotherapy when pos-
sible. Post-menopausal patients with positive receptor status
received tamoxifen. Patients with a tumour larger than
30 mm were given chemotherapy prior to any other treat-
ment when possible (according to age, clinical state and
acceptance of patients), using modalities previously reported
(Calais et al., 1993). The initial diagnosis was then based on
a biopsy of the primary tumour without axillary dissection.
After completion of three cycles of primary chemotherapy,
tumour response was assessed by both a surgical and a
medical oncologist, on the basis of the reduction in tumour
size. When the tumour regression was 50% or less, a mastec-
tomy was performed, followed by radiation therapy and by
six additional cycles of chemotherapy. When the regression
was greater than 50%, local treatment was radiation alone
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usng external radiotherapy and an interstital implant as a
boost to the initial location of the tumour, followed by six
additional cycles of chemotherapy.
Adipose tissue preparation andfatty acids analysis
Samples of adipose tissue were prepaed during the first
surgery, free of epitbelial tissue, and kept frozen in liquid
nitrogen until analysis. All analyses were performed in a
blinded manner. The procedures for preparation of fatty
acids have been reported elswhere (Chajes et al., 1992). In
smary, total lipids of the adipose tissue were extracted,
and triglycerides purified on silica gel G thin-layer
chromatographic plates. Fatty acids were analysed as methyl
esters by gas chromatography on a fused-siLica capillary col-
umn with a liquid phase of Carbowax 20 M, using an on-
column injector and a flame ionisation detector, under
operating conditions already described (Martin et al., 1991).
Fatty acids were identified and quantified with the use of
commercial stndards (Nu-Check-Prep, Eliian, MN, USA).
All solvents were high-performance liquid chromatography
(HPLC) grade, and nitrogen was used at each step. Inter-
assay and intra-assay coefficients of variation have been
reported (Chajes et al., 1992).
Statistical analysis
Data were analysed using the SAS statistical software (SAS/
STAT User's Guide, Version 6, 4th edn, Cary, NC, SAS
Institute). Each fatty acid was expressed as a percentage of
the total peak area. The associations between fatty acids and
clinical characteristics of the patients were measured by
Spearman's rank-order correlation coefficients. Log-rankr
tests (Mantel & Haenszel, 1959) were used to study the
prognostic value on metastasis occurrnce of conventional
prognostic factors and of adipose tissue fatty acids. For each
fatty acid, the median content was used as a cut-off value.
The metastasis-free curves were estimated by the Kap-
lan-Meier method (Kaplan & Meier, 1958). The initial time
of the study was the initial treatment of the tumour (surgery
or preoperative chemotherapy), the end-point date was the
date of first metastasis or of last follow-up. All prognostic
factors reaching the 10% sig n level in the univariate




During the observation period (mean 31.2 months; range
8-51 months), 21 patients developed visceral metastases. The
prognostic value on the risk of metastases has been studied
for conventional factors (Table I). A tumour diameter larger
than 50 mm increased the risk by 5.5-fold (P = 0.0003). The
risk of metaa was 2.6 times greater when the level of
oestrogen receptors was below 10 fmolmg-' than when it
was above this value.
Initial axidlary lymph node involvement was not deter-
mined for the 29 patients who received preoperative
chemotherapy because of the large size of their tumours.
Among the 92 other patients, 44 had axillary lymph node
involvement. The risk of metastases did not vary significantly
with nodal status or progesterone level.
Univariate analysis ofbreast asipose tissuefatty acids (Table
II)
The 18:3,3 level in breast fat was significantly related to the
risk of subsequent metastases. The risk was divided by 5
when the level of 18:3,3 was above 0.38% compared with
when it was lower. Low levels ofpalmitic acid (16:0) and of
docosahexaenoic acid (22:6,3) were also associated with an
increased ris of metastasis (Table II).
Multivariate analysis
The 18:3,3 level and tumour size were the variables found to
increase the global predictive vahle of the Cox model (Table
HI). The improvement subsequent to entering other variables
was not staistically sgnificant. The risk of metastasis was
multiplied by 4.3 when the breast fat 18:3,3 level was lower
than 0.38% as compared with when it was greater than
0.38%. The risk was multiplied by 4.7 when the diameter of
the tumour was larger than 5 cm.
Since the a-linolenic acid level in breast fat seemed to be
the first independent predictive factor of prognosis, actuarial
probability of metastasis-free survival was plotted in the two
groups of patients defined by the 18:3.3 level (Figure 1). The
relationship between 18:3,3 level and prognostic factors was
examined. A low level of 18:3,3 in adipose breast tiss was
associated with positive axillary lymph node status and with
vascular invasion, but not with tumour size or mitotic
index.
Tablk I Clinical charactestics of breast tumours and risk of metastasis
Patients Patients with Relative risk of metastasis
Prognostic factor (n = 121) metastasis (95% cm#idene internal) P-value
Tumour size (mm)
<50 103 13 1.0
> 50 18 8 5.5 (2.2-13.8) 0.0003
Nodal status'
Neptive 48 7 I.Ob
Positive 44 10 1.7 (0.6-4.4) NSd
Mitotic index'
I or II 61 6 1.0"
111 58 15 2.9 (1.1-7.5) 0.03
Vascular invasion'
Absent 76 9 1.0"
Present 41 12 2.8 (1.2-6.6) 0.02
Oestrogen receptor (fmol mg-'
' 10 101 15 1.0
< 10 16 5 2.6 (0.9-7.1) 0.06
Progesterone receptor (fmol mg 'f
>10 85 13 1.Ob
A 10 32 7 1.8 (0.7-4.5) NSd
"Lrank test. "Refence category. 'Unavailable for 29 patients with preoperative chemothery. dNS,
not significant (P>0.1O). cUnavailabk for two patints. fUnavailable for four patients.332 P. BOUGNOUX et al.
Table H Univariate analysis on fatty acids in breast adipose tissue
Patients with
Fatty acid Patients metastasis Relative risk of metastasis
(%)a (n = 121) (n = 21) (95% confidence interval) P-value"
Saturates
16:0 (palmitic acid)
<22.9 61 14 .ff
22.9 60 7 0.4 (0.1-0.9) 0.03
18:0 (stearic acid)
<5.94 61 11 L.0'
, 5.94 60 10 0.7 (0.3-1.6) NSd
Monounsaturates
16:1 (palnitoleic acid)
<3.81 61 1 1 L.0
3.81 60 10 0.9 (0.4-2.2) NSd
18: 1 -9 (okeic acid)
<42.05 61 11 1.O
)42.05 60 10 0.9 (0.4-2.1) NSd
Polysaturates n-6
18:2. (linoleic acid)
< 14.58 60 9 I.ff
, 14.58 61 12 1.3 (0.5-3.0) NSd
20:4,6 (arachidonic acid)
<0.30 59 9 1.0:
;N0.30 62 12 1.7 (0.7-4.1) NS"
22:4.6 (nervonic acid)
<0.14 59 9 1f.
; 0.14 62 12 1.7 (0.7-4.1) NSd
Polyunsaturates n-3
18:3,.3 (a-1inokenic acid)
<0.38 60 17 1f.
0.38 61 4 0.2 (0.1-0.6) 0.004
22:5,3 (docosapentaenoic acid)
<0.20 58 14 1.ff
0.20 63 7 0.5 (0.2-1.2) NS1
22:6_3 (docosahexaenoic acid)
<0.17 56 14 I.f
,0.17 65 7 0.4 (0.2-1.0) 0.06
'Percentage of total fatty acids. bLog-rank test. cReference category. dNS, not significant.
Table M Multivariate analysis of prognostic factors
Relative risk
Prognostic factor (95% confidence interval) P-vahe
a-Linokenic acid (18:3,3) (%)
>0.38 1.ob 0.009
<0.38 4.3 (1.4-13)
Tumour clinical size (mm)
50 1.0b 0.001
> 50 4.7 (1.9-12)
Global chi-square: 19.5 with 2 d.f. (P = ).0001). aWald test.
bReference category.
Dea
We present data relating occurrence of metastases to a
decreased level of a-linolenic acid in adipose breast tissue of
breast cancer patients. Although local relapses may reflect
the biological aggressiveness of the carcinoma in a way
similar to the development of distant metastases, these events
were not taken into account in the present study because
their occurrence is known to be influenced by the local
treatment.
The site of sampling that we used was the breast, close to
the carcinoma. Metabolic interactions exist between adipose
tissue and breast epithelium (Kidwell, 1989; Carroll &
Parenteau, 1992), and the tumour may recruit its fatty acids
from breast adipocytes. The properties of 18:3,3 may make
its selective removal plausible. White adipose tissue fatty
acids have different rates of mobilisation, which increases
with their unsaturation and reduced chain length and is
greater for n-3 than for n-6 polyunsaturates (Raclot & Gros-
















Figwe 1 Metastasis-free survival according to the breast adipose
tissue level of 18:3.3. The threshold for 18:3,,3 is the median
(log-rank- value 10.29, P<0.001).
tion index than other major fatty acids commonly found in
human adipose tissue. Like other essential fatty acids, 18:3,3
is desaturated and elongated to produce long-chain n-3
polunsaturates. But its metabolism differs in that it is more
rapidly oxidised than all other 16- to 22-carbon fatty acids
(Cunnane, 1991), and it is always present in very low
amounts in storage tissues. Therefore, the possibility exists
that the low level of 18:3,,3 observed in breast cancer patients
with poor prognosis could be a consequence of its high rate
of mobilisation, or of its preferential oxidation to fulfil
specific needs for tumour growth and/or host aggression.
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of 18:3,3 in the adipose tissue and the size of the primary
tumour or the mitotic index suggests that a low level of
18:3,3 in breast fat is not induced by growth of the vicinal,
pnmary tumour, and makes it unlikely that it might be the
consequence of distant occult metastatic growth occurring
simultaneously in the same patient.
We have previously reported that in breast cancer patients
the 18:3,3 level in breast adipose tissue is correlated with the
18:3,3 level in gluteal adipose tissue (Chajes et al., 1992),
suggesting that its level in breast might reflect the body
reserves ofthis fatty acid. A possible cause ofdepleted 18:3,j3
in adipose stores is insufficient intake of this fatty acid. In
contrast to the numerous reports relating long-chain polyun-
saturate intake with the corresponding fatty acid content of
adipose tissue, there have been few studies of the association
between the intake of 18:3,,3 and its level in adipose tissue. A
weak correlation with dietary intake was reported for this
fatty acid in a recent study, but the correlation was much
higher in the subpopulation of patients with stable weight
(London et al., 1991). This agrees with the observation that
this fatty acid is selectively oxidised during weight loss
achieved by low-calorie dieting in obese patients (Phinney et
al., 1990; Hudgins & Hirsch, 1991). No weight loss had
occurred in our population ofpatients at the time ofanalysis
of their adipose tissue. Therefore breast cancer patients with
a low level of 18:3,3 in adipose breast tissue may have a
reduced dietary intake of 18:3,3.
The possibility that dietary fat might alter the outcome of
breast cancer has been examined in some epidemiological
studies, and conclusive evidence for a role of one individual
fatty acid has been precluded by methodological limitations
in the measurement of fatty acid intake (Greenwald, 1989;
Prentice et al., 1989). Decreased breast cancer incidence and
improved survival has been reported to be associated with a
high proportion ofdietary fat originating from fish (Kaizer et
al., 1989) enriched in long-chain n-3 polyunsaturated fatty
acids (PUFAs). Among the dietary surveys, one found that
the risk of death from breast cancer increased with fat intake
(Gregorio et al., 1985), and another did not (Newman et al.,
1986). However, the dietary questionnaires used in these
studies did not allow qualitative estimation of the type of fat
ingested. Recently, associations have been reported between
total fat or saturated and polyunsaturated fat intakes
evaluated at the time of diagnosis and treatment failure in
oestrogen-receptor positive breast cancer (Holm et al., 1993).
However, no details were available to distinguish n-6 or n-3
families of polyunsaturates for their possible opposite effects
on relapses. In contrast, the Multiple Risk Factor Interven-
tion Trial (MRFIT) reported significant associations between
cancer mortality and the ratio of dietary 18:3,3 to 18:2,,, or
the ratio of total n-3 to n-6 PUFAs (Dolecek, 1992).
Although the study did not involve breast cancer, it suggests
that the composition of dietary fat, and specifically its con-
tent of different essential fatty acids, may influence cancer
rates and death. In experimental animal models ofmammary
carcinogenesis, high n-6 PUFA diets stimulate mammary
tumour growth and development as well as metastases (Car-
roll, 1986; Erickson & Hubbard, 1990), while long-chain n-3
PUFA (Adams et al., 1990; Cave, 1991) or 18:3,,3 enrichment
ofthe diet (Tinsley et al., 1981; Kamano et al., 1989; Fritsche
& Johnston, 1990; Hirose et al., 1990) inhibits tumour
growth. Therefore, in the rat, the effects ofdietary long-chain
n-3 PUFAs seem to oppose the stimulation of tumour
growth induced by n-6 essential fatty acids (Lands, 1992),
and 18:3,3 appears also to bear inhibitory properties.
There is presently no direct mechanism relating 18:3,3
level in the adipose breast tissue to properties of the tumour
cells or to host-dependent factors leading to subsequent
development of visceral metastases. In contrast with this
situation, other prognostic markers of breast cancer fre-
quently indicate properties specifically related to the invasive
behaviour of cancer ceUs (Koscielny et al., 1989), or proper-
ties related to molecular alterations of the tumour ceUs (i.e.
the presence of steroid hormone receptors or growth factor
receptors, acquired genetic abnormalities) or properties
related to the response of the host to tumour growth. Several
markers of breast cancer prognosis derived from the stromal
response of the host have recently been described, such as
stromelysin 3 secretion by stromal ceUls (Basset et al., 1990)
or the angiogenic response of the host to the tumour growth
(Weidner et al., 1992). The fact that a low 18:3,3 level was
related to positive lymph node status and to the presence of
vascular invasion suggests a possible association between this
fatty acid and mechanisms of tumour cell invasiveness.
The main cause of death in breast cancer patients is the
development of distant metastases. Since a reduced 18:3,3
content of breast adipose tissue appears to be the first deter-
minant of their occurrence in our series of patients, dietary
supplementation of breast cancer patients in conditions
leading to a replenishment of adipose stores of 18:3,3 might
delay or even prevent their clinical appearance. If 18:3,3 is
actually involved in the metastatic process, the mechanisms
leading to its reduction in the adipose tissue must be under-
stood before any dietary intervention is contemplated.
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